PRO MEDICUS LIMITED — Director's Dealing 2024

Oct 29, 2024

Listing Rule 3.19A.2

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity	Pro Medicus Limited
ABN	25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Alice WILLIAMS
Date of last notice	26 August 2024

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.	Ordinary fully paid shares in Pro MedicusLimited held by Alice WILLIAMS
Date of change	30 October 2024
No. of securities held prior to change	2,910
Class	Ordinary shares
Number acquired	Nil
Number disposed	850 Ordinary shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation	$189.27 per share

Appendix 3Y

+ See chapter 19 for defined terms.

No. of securities held after change	2,060 ordinary shares consisting off:-900 ordinary shares held under AliceWILLIAMS810ordinarysharesheldunderStrategic Analytics (Aust) Pty LtdNil ordinary shares held underMr Charles Morrice WilliamsC/- Bond Street Custodians350ordinarysharesheldunderStrategic Analytics (Aust) Pty Ltd
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	On market disposal. Divestment of 850ordinary shares held under the estate of thelate Mr Charles Morrice Willams. Nil balanceleft after the divestment.

Part 2 – Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A

+ See chapter 19 for defined terms.

Interest after change	N/A

Part 3 – +Closed period

Were the interests in the securities or contracts detailedabove traded during a +closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

Danny English Company Secretary 30 October 2024

+ See chapter 19 for defined terms.